ECL · 10-Q · 2026Q3 · Full report

Segment Profitability

ECOLAB INC. · 2026-10-29 · Importance 48 · Surprise 40

Third-quarter fixed-currency operating income was $445.2 million for Global Water, $404.9 million for Global Institutional & Specialty, $73.9 million for Global Pest Elimination and $50.2 million for Global Life Sciences. Global Institutional & Specialty's organic margin rose 1.1 percentage points to 24.7%, while Life Sciences' rose 5.0 points to 23.3%, reflecting pricing and productivity or supply-chain efficiencies partly offset by investment and commodity costs. Global Water's organic margin increased 0.1 points to 17.5% in the quarter, while Pest Elimination's decreased 0.1 points to 20.8%; corporate operating income was a loss of $161.9 million at fixed currency.

Key facts

• Global Water's Q3 2026 organic operating margin increased 0.1 percentage points; strong pricing and productivity contributed 5.0 points, offset by 4.6 points from business investments and higher commodity costs. source
• Global Water's organic operating margins decreased 0.2 percentage points for the first nine months of 2026; 3.3 points of negative impact from investments and higher commodity costs were partially offset by 3.5 points from pricing and productivity. source
• Global Institutional & Specialty organic operating margins increased 1.1 percentage points in Q3 2026 and 1.2 percentage points in the first nine months. source
• Global Pest Elimination's Q3 2026 organic operating margin decreased 0.1 percentage points; investments including pest intelligence had a 4.8-point negative impact, partly offset by 4.4 points from pricing, volume, and productivity. source
• Global Pest Elimination's organic operating margins increased 0.4 percentage points in the first nine months of 2026; 4.5 points of positive impact from pricing, productivity and volume were partly offset by 4.6 points from investments including pest intelligence. source
• Global Life Sciences organic operating margins increased 5.0 percentage points in Q3 2026; supply chain efficiencies and pricing contributed 14.2 points, partly offset by 8.6 points from investments and higher commodity costs. source
• Global Life Sciences organic operating margins increased 4.1 percentage points in the first nine months of 2026; 9.7 points from pricing, supply chain efficiencies and volume were partly offset by 5.6 points from investment, commodity costs and mix. source